Percutaneous coronary intervention for bifurcation coronary lesions using optimised angiographic guidance: the 18th consensus document from the European Bifurcation Club
- PMID: 38752714
- PMCID: PMC11285041
- DOI: 10.4244/EIJ-D-24-00160
Percutaneous coronary intervention for bifurcation coronary lesions using optimised angiographic guidance: the 18th consensus document from the European Bifurcation Club
Abstract
The 2023 European Bifurcation Club (EBC) meeting took place in Warsaw in October, and the latest evidence for the use of intravascular ultrasound (IVUS) and optical coherence tomography (OCT) to optimise percutaneous coronary interventions (PCI) on coronary bifurcation lesions (CBLs) was a major focus. The topic generated deep discussions and general appraisal on the potential benefits of IVUS and OCT in PCI procedures. Nevertheless, despite an increasing recognition of IVUS and OCT capabilities and their recognised central role for guidance in complex CBL and left main PCI, it is expected that angiography will continue to be the primary guidance modality for CBL PCI, principally due to educational and economic barriers. Mindful of the restricted access/adoption of intracoronary imaging for CBL PCI, the EBC board decided to review and describe a series of tips and tricks which can help to optimise angiography-guided PCI for CBLs. The identified key points for achieving an optimal angiography-guided PCI include a thorough analysis of pre-PCI images (computed tomography angiography, multiple angiographic views, quantitative coronary angiography vessel estimation), a systematic application of the technical steps suggested for a given selected technique, an intraprocedural or post-PCI use of stent enhancement and a low threshold for bailout use of intravascular imaging.
Conflict of interest statement
F. Burzotta has received speaker fees from Medtronic, Abiomed, Abbott, and Terumo. J.F. Lassen has received speaker fees from Medtronic, Boston Scientific, Biotronik, and Abbott. R. Albiero has received speaker fees from Medtronic and Abbott. J. Legutko has received speaker fees from Abbott, Insight Lifetech, Philips, and Procardia. M. Pan has received speaker fees from Abbott, Boston Scientific, and Asahi. Y.S. Chatzizisis has received speaker fees/consultancy/research funding from Boston Scientific and Medtronic; and is co-founder of ComKardia Inc. T.W. Johnson has received speaker/consultancy fees from Abbott, Boston Scientific, Cordis, Medtronic, Shockwave Medical, and Terumo; and has received research funding from Abbott. A. Chieffo has received speaker/consultant fees from Abbott, Abiomed, Biosensors, Boston Scientific, Medtronic, and Menarini. G. Stankovic has received speaker fees from Medtronic, Abbott, Boston Scientific, and Terumo. M. Lesiak has received speaker fees from Abbott, Biotronik, Boston Scientific, Medtronic, Philips, and Terumo. T. Lefèvre has received minor fees from Terumo, Boston Scientific, Abbott, and Edwards Lifesciences. C. Collet has received a research grant and speaker fees and been on advisory board for Boston Scientific; has received a research grant and speaker fees from GE HealthCare, Insight Lifetech, Siemens Healthineers, HeartFlow, and Shockwave Medical; has received a research grant from Medis Medical Imaging, and Pie Medical; has stock options in Medyria; and has been a research director and equity holder of CoreAalst. O. Darremont reports support from Boston Scientific, Abbott, and Edwards Lifesciences. P.W. Serruys has received consulting fees from SMT, Meril Life Sciences, Novartis, Philips, and Xeltis. The other authors have no conflict of interest to declare.
Figures
References
-
- Burzotta F, Lassen JF, Lefèvre T, Banning AP, Chatzizisis YS, Johnson TW, Ferenc M, Rathore S, Albiero R, Pan M, Darremont O, Hildick-Smith D, Chieffo A, Zimarino M, Louvard Y, Stankovic G. Percutaneous coronary intervention for bifurcation coronary lesions: the 15th consensus document from the European Bifurcation Club. EuroIntervention. 2021;16:1307–17. - PMC - PubMed
-
- Burzotta F, Lassen JF, Banning AP, Lefèvre T, Hildick-Smith D, Chieffo A, Darremont O, Pan M, Chatzizisis YS, Albiero R, Louvard Y, Stankovic G. Percutaneous coronary intervention in left main coronary artery disease: the 13th consensus document from the European Bifurcation Club. EuroIntervention. 2018;14:112–20. - PubMed
-
- Burzotta F, Lassen JF, Louvard Y, Lefèvre T, Banning AP, Daremont O, Pan M, Hildick-Smith D, Chieffo A, Chatzizisis YS, Džavík V, Gwon HC, Hikichi Y, Murasato Y, Koo BK, Chen SL, Serruys P, Stankovic G. European Bifurcation Club white paper on stenting techniques for patients with bifurcated coronary artery lesions. Catheter Cardiovasc Interv. 2020;96:1067–79. - PMC - PubMed
-
- Albiero R, Burzotta F, Lassen JF, Lefèvre T, Banning AP, Chatzizisis YS, Johnson TW, Ferenc M, Pan M, Daremont O, Hildick-Smith D, Chieffo A, Louvard Y, Stankovic G. Treatment of coronary bifurcation lesions, part I: implanting the first stent in the provisional pathway. The 16th expert consensus document of the European Bifurcation Club. EuroIntervention. 2022;18:e362–76. - PMC - PubMed
-
- Lassen JF, Albiero R, Johnson TW, Burzotta F, Lefèvre T, Iles TL, Pan M, Banning AP, Chatzizisis YS, Ferenc M, Dzavik V, Milasinovic D, Darremont O, Hildick-Smith D, Louvard Y, Stankovic G. Treatment of coronary bifurcation lesions, part II: implanting two stents. The 16th expert consensus document of the European Bifurcation Club. EuroIntervention. 2022;18:457–70. - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
